302440 — SK Bioscience Co Share News
0.000.00%
Last trade - 00:00- KR₩3tn
- KR₩3tn
- KR₩651bn
GSK, SK Bioscience start late-stage trials of COVID-19 vaccine
S. Korea approves Phase III trial of SK Bioscience's COVID-19 vaccine
S.Korea's Moon pledges $1.92 bln by 2025 to boost COVID-19 vaccine production (updated)
S.Korea's SK bioscience to invest $132 mln to boost vaccine production
S.Korea pledges $200 million to international COVID-19 vaccine effort
Samsung BioLogics shares ease after jumping on vaccine deal (updated)
Novavax agrees on expansion of COVID-19 vaccine production in South Korea
Brief: Novavax Announces Memorandum Of Understanding To Explore Expansion Of Covid-19 Vaccine Activities In South Korea
SK bioscience's COVID-19 vaccine plant in South Korea gets European nod
S.Korean vaccine firm SK Bioscience sees shares soar 30% on debut (updated)
Vaccine developer SK Bioscience shares debut at double IPO price